Attralus, Inc.
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.attralus.com
Clinical Trials
4
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
A Study of AT-02 in Subjects With Systemic Amyloidosis.
- First Posted Date
- 2023-07-18
- Last Posted Date
- 2025-08-24
- Lead Sponsor
- Attralus, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT05951049
- Locations
- 🇺🇸
Kansas City, Kansas City, Kansas, United States
🇺🇸Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸OHSU (Oregon Health & Science University), Portland, Oregon, United States
Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis
- First Posted Date
- 2022-08-30
- Last Posted Date
- 2024-04-03
- Lead Sponsor
- Attralus, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT05521022
- Locations
- 🇺🇸
Midwest Heart and Vascular, Overland Park, Kansas, United States
🇺🇸Johns Hopkins, Baltimore, Maryland, United States
🇺🇸St. Luke's Hospital of Kansas City, Kansas City, Missouri, United States
A Study to Evaluate Organ Level Uptake Repeatability of 124I AT-01 in Subjects With Systemic Amyloidosis
- Conditions
- Amyloidosis
- Interventions
- Drug: I124-AT01 only
- First Posted Date
- 2022-02-11
- Last Posted Date
- 2024-07-31
- Lead Sponsor
- Attralus, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT05235269
- Locations
- 🇺🇸
PET/CT Imaging of Berkeley, Berkeley, California, United States
🇺🇸Northern California PET Imaging Center, Sacramento, California, United States
🇺🇸PET/CT Imaging of San Jose, San Jose, California, United States
A Study to Characterize the Biodistribution of 124I-Labeled AT-03 in Patients With Systemic Amyloidosis
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2022-09-15
- Lead Sponsor
- Attralus, Inc.
- Target Recruit Count
- 13
- Registration Number
- NCT05201911
- Locations
- 🇺🇸
University of Tennessee Medical Center, Knoxville, Tennessee, United States